Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide
- 25 October 2025
- 1 week ago
GLP-1 Agonists Linked to Increased Nutritional Deficiencies, Reveals Research
- 25 October 2025
- 1 week ago
FDA Approves Oral Semaglutide for Cardiovascular Risk Reduction in Type 2 Diabetes
- 23 October 2025
- 1 week ago
Recent News
Madras HC grants bail to man accused of forging NE...
- 01 November, 2025
AIIMS INI SS January 2026: 4 seats added in 2 spec...
- 01 November, 2025
Treatment in Myocardial Infarction and Non-Obstruc...
- 01 November, 2025
PG medical admissions 2025 commence in Bihar, chec...
- 01 November, 2025
Assam to begin NEET PG 2025 counselling from Novem...
- 01 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









